As previously reported, Macquarie downgraded GameStop (GME) to Neutral from Outperform and lowered its price target to $23 from $27. Analyst Ben Schachter said GameStop is "fighting" to diversify into new businesses as the core console game industry faces challenges and does not confidence that the company, or anyone can accurately forecast 2017 console market growth. Additionally, the analyst is more cautious on GameStop's near-term outlook due to lack of management credibility following recent revenue misses, concerns on used game demand if new games do not rebound, uncertain cash flow, growing Amazon (AMZN) competition, and limited insider buying.

Latest data shows the largest indicative borrow rate increases among liquid option names include: Luminar Technologies (LAZR) 13.08% +3.40, Lithium Americas (LAC) 39.35% +2.00, Rumble (RUM) 33.08% +1.07, Cutera (CUTR) 65.23% +0.93, Gorilla Technology Group Inc (GRRR) 49.06% +0.53, Aquestive Therapeutics (AQST) 0.99% +0.44, Medical Properties Trust (MPW) 16.94% +0.20, Nikola (NKLA) 22.04% +0.17, SunPower (SPWR) 3.29% +0.16, and GameStop (GME) 1.74% +0.16.